SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001619856-24-000038
Filing Date
2024-05-07
Accepted
2024-05-07 16:15:25
Documents
88
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crbu-20240331.htm   iXBRL 10-Q 998260
2 EX-31.1 crbu-20240331xexx311.htm EX-31.1 10313
3 EX-31.2 crbu-20240331xexx312.htm EX-31.2 10317
4 EX-32.1 crbu-20240331xexx321.htm EX-32.1 4685
5 EX-32.2 crbu-20240331xexx322.htm EX-32.2 4674
  Complete submission text file 0001619856-24-000038.txt   6727360

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20240331.xsd EX-101.SCH 50974
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crbu-20240331_cal.xml EX-101.CAL 69241
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crbu-20240331_def.xml EX-101.DEF 219798
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20240331_lab.xml EX-101.LAB 651446
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20240331_pre.xml EX-101.PRE 469317
92 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20240331_htm.xml XML 943596
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40631 | Film No.: 24922067
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)